These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34122413)

  • 1. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses.
    Cao Y; Xu X; Kitanovski S; Song L; Wang J; Hao P; Hoffmann D
    Front Immunol; 2021; 12():656433. PubMed ID: 34122413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.
    Wang G; Verma AK; Guan X; Bu F; Odle AE; Li F; Liu B; Perlman S; Du L
    J Virol; 2024 Sep; 98(9):e0037624. PubMed ID: 39189731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
    Ansariniya H; Seifati SM; Zaker E; Zare F
    Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response.
    Kindler E; Thiel V; Weber F
    Adv Virus Res; 2016; 96():219-243. PubMed ID: 27712625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.
    Motavalli R; Abdelbasset WK; Rahman HS; Achmad MH; Sergeevna NK; Zekiy AO; Adili A; Khiavi FM; Marofi F; Yousefi M; Ghoreishizadeh S; Shomali N; Etemadi J; Jarahian M
    IUBMB Life; 2021 Aug; 73(8):1005-1015. PubMed ID: 34118117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity.
    Coden ME; Loffredo LF; Abdala-Valencia H; Berdnikovs S
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
    Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of lethal human coronaviruses.
    Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
    Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY6E impairs coronavirus fusion and confers immune control of viral disease.
    Pfaender S; Mar KB; Michailidis E; Kratzel A; Boys IN; V'kovski P; Fan W; Kelly JN; Hirt D; Ebert N; Stalder H; Kleine-Weber H; Hoffmann M; Hoffmann HH; Saeed M; Dijkman R; Steinmann E; Wight-Carter M; McDougal MB; Hanners NW; Pöhlmann S; Gallagher T; Todt D; Zimmer G; Rice CM; Schoggins JW; Thiel V
    Nat Microbiol; 2020 Nov; 5(11):1330-1339. PubMed ID: 32704094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.
    Shahrajabian MH; Sun W; Cheng Q
    Hum Vaccin Immunother; 2021 Jan; 17(1):62-83. PubMed ID: 32783700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).
    Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Mohaini MA; Aldali J; Tirupathi R; Sule AA; Koritala T; Adhikari R; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Sami SA; Mitra S; Pandey MK; Harapan H; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7162-7184. PubMed ID: 34859882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immune Responses against Coronavirus Infections: Friend or Foe?
    Vafaeinezhad A; Atashzar MR; Baharlou R
    Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.